What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Enzyme
- Gene
Juan Tamargo mainly investigates Internal medicine, Cardiology, Atrial fibrillation, Endocrinology and Pharmacology.
His study in Blood pressure, Electrocardiography, Disease, Anti-Arrhythmia Agents and Sodium nitroprusside is carried out as part of his Internal medicine studies.
While the research belongs to areas of Cardiology, Juan Tamargo spends his time largely on the problem of Guideline, intersecting his research to questions surrounding Medical education.
His work deals with themes such as ANTIARRHYTHMIA AGENTS and Heart Rhythm, which intersect with Atrial fibrillation.
He interconnects Mechanism of action, Biochemistry, Guinea pig, Torsades de pointes and Cardiac action potential in the investigation of issues within Pharmacology.
His Heart failure research incorporates themes from Ambulatory blood pressure, Defibrillation, Implantable cardioverter-defibrillator and Sick sinus syndrome.
His most cited work include:
- 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). (11730 citations)
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (3899 citations)
- Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (3367 citations)
What are the main themes of his work throughout his whole career to date?
Juan Tamargo spends much of his time researching Internal medicine, Endocrinology, Cardiology, Pharmacology and Electrophysiology.
His study in Atrial fibrillation, Heart failure, Calcium, Nitric oxide and Vasodilation is done as part of Internal medicine.
His work is dedicated to discovering how Endocrinology, Membrane potential are connected with Depolarization and Papillary muscle and other disciplines.
His study in the field of Heart Rhythm and Coronary artery disease also crosses realms of Task force.
The Pharmacology study combines topics in areas such as Propafenone, Flecainide, Blood pressure and Potassium channel.
His study looks at the relationship between Electrophysiology and fields such as Biophysics, as well as how they intersect with chemical problems.
He most often published in these fields:
- Internal medicine (58.81%)
- Endocrinology (34.29%)
- Cardiology (21.43%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (58.81%)
- Cardiology (21.43%)
- Intensive care medicine (7.38%)
In recent papers he was focusing on the following fields of study:
Juan Tamargo mostly deals with Internal medicine, Cardiology, Intensive care medicine, Pharmacotherapy and Heart failure.
Juan Tamargo combines subjects such as Endocrinology and MEDLINE with his study of Internal medicine.
Juan Tamargo has researched Cardiology in several fields, including Familial atrial fibrillation and Aspirin.
His study in Intensive care medicine is interdisciplinary in nature, drawing from both Medical prescription, Clinical trial and Cardiovascular agent.
As a member of one scientific family, Juan Tamargo mostly works in the field of Pharmacotherapy, focusing on Position paper and, on occasion, Alternative medicine, Cholesterol, Lipid management, Rheumatoid arthritis and Lipid metabolism.
His research in Heart failure tackles topics such as Diabetes mellitus which are related to areas like Adverse effect and Kidney disease.
Between 2016 and 2021, his most popular works were:
- 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) (425 citations)
- Gender differences in the effects of cardiovascular drugs (100 citations)
- Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). (64 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Gene
The scientist’s investigation covers issues in Internal medicine, Pharmacotherapy, Diabetes mellitus, Cardiology and Renin–angiotensin system.
Juan Tamargo has included themes like Endocrinology and MEDLINE in his Internal medicine study.
His Pharmacotherapy research is multidisciplinary, incorporating elements of Alternative medicine, Position paper, Atrial fibrillation and Intensive care medicine.
His Atrial fibrillation research integrates issues from Ventricular tachycardia, Bradycardia and Sudden cardiac death.
Percutaneous coronary intervention is the focus of his Cardiology research.
His research integrates issues of Aldosterone Receptor Antagonist, Chymase, Hyperkalemia and Pharmacology in his study of Renin–angiotensin system.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
